Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 5,901 | 3,339 | 872 | 0 | 1,219 |
| Gross Profit | 5,901 | 3,339 | 872 | N/A | 1,219 |
| Operating Expenses | 21,459 | 20,506 | 18,483 | 0 | 14,266 |
| Operating Income | -15,558 | -17,167 | -17,611 | N/A | -13,047 |
| Interest Expense | 4,428 | 3,405 | 2,451 | 0 | 2,670 |
| Other Income | -511 | 2,687 | -31 | 0 | -3,546 |
| Pre-tax Income | -20,497 | -17,885 | -20,093 | 0 | -19,263 |
| Income Tax | N/A | N/A | N/A | N/A | 900 |
| Net Income Continuous | -20,497 | -17,885 | -20,093 | N/A | -20,163 |
| Net Income | $-20,497 | $-17,885 | $-20,093 | $N/A | $-20,163 |
| EPS Basic Total Ops | -0.77 | -0.99 | -1.11 | N/A | -1.11 |
| EPS Basic Continuous Ops | -0.77 | -0.99 | -1.11 | N/A | -1.11 |
| EPS Diluted Total Ops | -0.77 | -0.99 | -1.11 | N/A | -1.11 |
| EPS Diluted Continuous Ops | -0.77 | -0.99 | -1.11 | N/A | -1.11 |
| EBITDA(a) | $-11,087 | $-12,638 | $-15,811 | $N/A | $-13,047 |